> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# A Better Life Marketing Unapproved ‘Stem Cell Therapy’: FDA
- URL: https://www.fdaweb.com/a-better-life-marketing-unapproved-stem-cell-therapy-fda/
- Published: 2021-07-20T12:00:00.000Z
- Updated: 2026-09-14T17:07:06.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5149746

The CBER Office of Compliance and Biologics Quality says A Better Life Stem Cell Center, Las Vegas, NV, is marketing cellular products that appear to be derived from umbilical cord or umbilical cord blood that A Better Life refers to as “stem cell therapy” for numerous diseases or conditions such as diabetes and Crohn’s disease. A 7/14 [Notice of Violation](https://www.fda.gov/media/150811/download?ref=fdaweb.com) says such products are legally regulated as drugs and biologic products and cannot be marketed without a valid BLA or IND.

A Better Life was told to respond to the Notice of Violation within 30 days.